Xiaowei Liu
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Ferroptosis and cancer prognosis
- Respiratory Support and Mechanisms
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Respiratory Support and Mechanisms 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Ferroptosis and cancer prognosis 2
-
- Spine and Intervertebral Disc Pathology 5
- Co-authors
- Deborah Lyn (1 shared paper)Nerimiah Emmett (1 shared paper)Cheng Cheng (3 shared papers)Zhixiang Wu (3 shared papers)Cheng Yang (4 shared papers)Xiaohe Li (4 shared papers)Kai Chen (3 shared papers)Honggang Zhou (4 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Biomedicine & Pharmacotherapy (2 papers)Cell Death Discovery (1 paper)International Immunopharmacology (1 paper)Phytomedicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaowei Liu
37 papers receiving 572 citations
Peers
Comparison fields: 5 of 113
- Pulmonary and Respiratory Medicine 161
- Cancer Research 54
- Pathology and Forensic Medicine 58
- Critical Care and Intensive Care Medicine 15
- Molecular Biology 166
Countries citing papers authored by Xiaowei Liu
This map shows the geographic impact of Xiaowei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Liu more than expected).
Fields of papers citing papers by Xiaowei Liu
This network shows the impact of papers produced by Xiaowei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Liu. The network helps show where Xiaowei Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 83 | |
| 2 | 2019 | 51 | |
| 3 | 2018 | 42 | |
| 4 | 2022 | 34 | |
| 5 | 2022 | 32 | |
| 6 | 2019 | 31 | |
| 7 | 2021 | 27 | |
| 8 | 2020 | 25 | |
| 9 | 2021 | 20 | |
| 10 | 2023 | 19 | |
| 11 | 2020 | 19 | |
| 12 | 2019 | 19 | |
| 13 | 2021 | 18 | |
| 14 | 2023 | 18 | |
| 15 | 2023 | 16 | |
| 16 | A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses. | 2002 | 16 |
| 17 | 2020 | 16 | |
| 18 | 2014 | 15 | |
| 19 | 2015 | 11 | |
| 20 | 2022 | 11 |
About Xiaowei Liu
Xiaowei Liu is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Epidemiology, Cancer Research and Surgery, having authored 44 papers that have together received 582 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (5 papers), Spine and Intervertebral Disc Pathology (5 papers), Advanced Steganography and Watermarking Techniques (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Neuroblastoma Research and Treatments (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (161 citations), Cancer Research (54 citations), Pathology and Forensic Medicine (58 citations), Critical Care and Intensive Care Medicine (15 citations) and Molecular Biology (166 citations). Xiaowei Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Deborah Lyn, Nerimiah Emmett, Cheng Cheng, Zhixiang Wu, Cheng Yang, Xiaohe Li, Kai Chen, Honggang Zhou, Shaoyan Gao and Lei Yang. Their work appears in journals such as Frontiers in Pharmacology, Biomedicine & Pharmacotherapy, Cell Death Discovery, International Immunopharmacology and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.